B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 47.95 CNY -1.15%
Market Cap: 20.1B CNY
Have any thoughts about
Betta Pharmaceuticals Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Betta Pharmaceuticals Co Ltd stock under the Base Case scenario is 59.1 CNY. Compared to the current market price of 47.95 CNY, Betta Pharmaceuticals Co Ltd is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
59.1 CNY
Undervaluation 19%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Betta Pharmaceuticals Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Betta Pharmaceuticals Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Betta Pharmaceuticals Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Betta Pharmaceuticals Co Ltd

Provide an overview of the primary business activities
of Betta Pharmaceuticals Co Ltd.

What unique competitive advantages
does Betta Pharmaceuticals Co Ltd hold over its rivals?

What risks and challenges
does Betta Pharmaceuticals Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Betta Pharmaceuticals Co Ltd.

Provide P/S
for Betta Pharmaceuticals Co Ltd.

Provide P/E
for Betta Pharmaceuticals Co Ltd.

Provide P/OCF
for Betta Pharmaceuticals Co Ltd.

Provide P/FCFE
for Betta Pharmaceuticals Co Ltd.

Provide P/B
for Betta Pharmaceuticals Co Ltd.

Provide EV/S
for Betta Pharmaceuticals Co Ltd.

Provide EV/GP
for Betta Pharmaceuticals Co Ltd.

Provide EV/EBITDA
for Betta Pharmaceuticals Co Ltd.

Provide EV/EBIT
for Betta Pharmaceuticals Co Ltd.

Provide EV/OCF
for Betta Pharmaceuticals Co Ltd.

Provide EV/FCFF
for Betta Pharmaceuticals Co Ltd.

Provide EV/IC
for Betta Pharmaceuticals Co Ltd.

Show me price targets
for Betta Pharmaceuticals Co Ltd made by professional analysts.

What are the Revenue projections
for Betta Pharmaceuticals Co Ltd?

How accurate were the past Revenue estimates
for Betta Pharmaceuticals Co Ltd?

What are the Net Income projections
for Betta Pharmaceuticals Co Ltd?

How accurate were the past Net Income estimates
for Betta Pharmaceuticals Co Ltd?

What are the EPS projections
for Betta Pharmaceuticals Co Ltd?

How accurate were the past EPS estimates
for Betta Pharmaceuticals Co Ltd?

What are the EBIT projections
for Betta Pharmaceuticals Co Ltd?

How accurate were the past EBIT estimates
for Betta Pharmaceuticals Co Ltd?

Compare the revenue forecasts
for Betta Pharmaceuticals Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Betta Pharmaceuticals Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Betta Pharmaceuticals Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Betta Pharmaceuticals Co Ltd compared to its peers.

Compare the P/E ratios
of Betta Pharmaceuticals Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Betta Pharmaceuticals Co Ltd with its peers.

Analyze the financial leverage
of Betta Pharmaceuticals Co Ltd compared to its main competitors.

Show all profitability ratios
for Betta Pharmaceuticals Co Ltd.

Provide ROE
for Betta Pharmaceuticals Co Ltd.

Provide ROA
for Betta Pharmaceuticals Co Ltd.

Provide ROIC
for Betta Pharmaceuticals Co Ltd.

Provide ROCE
for Betta Pharmaceuticals Co Ltd.

Provide Gross Margin
for Betta Pharmaceuticals Co Ltd.

Provide Operating Margin
for Betta Pharmaceuticals Co Ltd.

Provide Net Margin
for Betta Pharmaceuticals Co Ltd.

Provide FCF Margin
for Betta Pharmaceuticals Co Ltd.

Show all solvency ratios
for Betta Pharmaceuticals Co Ltd.

Provide D/E Ratio
for Betta Pharmaceuticals Co Ltd.

Provide D/A Ratio
for Betta Pharmaceuticals Co Ltd.

Provide Interest Coverage Ratio
for Betta Pharmaceuticals Co Ltd.

Provide Altman Z-Score Ratio
for Betta Pharmaceuticals Co Ltd.

Provide Quick Ratio
for Betta Pharmaceuticals Co Ltd.

Provide Current Ratio
for Betta Pharmaceuticals Co Ltd.

Provide Cash Ratio
for Betta Pharmaceuticals Co Ltd.

What is the historical Revenue growth
over the last 5 years for Betta Pharmaceuticals Co Ltd?

What is the historical Net Income growth
over the last 5 years for Betta Pharmaceuticals Co Ltd?

What is the current Free Cash Flow
of Betta Pharmaceuticals Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Betta Pharmaceuticals Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Betta Pharmaceuticals Co Ltd

Current Assets 1.2B
Cash & Short-Term Investments 465.4m
Receivables 376.1m
Other Current Assets 343m
Non-Current Assets 8B
Long-Term Investments 1.6B
PP&E 2.7B
Intangibles 3.6B
Other Non-Current Assets 39m
Current Liabilities 1.7B
Accounts Payable 669m
Accrued Liabilities 325.8m
Short-Term Debt 150m
Other Current Liabilities 546.4m
Non-Current Liabilities 2B
Long-Term Debt 1.7B
Other Non-Current Liabilities 291.5m
Efficiency

Earnings Waterfall
Betta Pharmaceuticals Co Ltd

Revenue
2.6B CNY
Cost of Revenue
-453.9m CNY
Gross Profit
2.2B CNY
Operating Expenses
-1.7B CNY
Operating Income
492.1m CNY
Other Expenses
-68.4m CNY
Net Income
423.7m CNY

Free Cash Flow Analysis
Betta Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Betta Pharmaceuticals Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive Net Income
50/100
Profitability
Score

Betta Pharmaceuticals Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Betta Pharmaceuticals Co Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
54/100
Solvency
Score

Betta Pharmaceuticals Co Ltd's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Betta Pharmaceuticals Co Ltd

Wall Street analysts forecast Betta Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Betta Pharmaceuticals Co Ltd is 51.1 CNY with a low forecast of 40.6 CNY and a high forecast of 63 CNY.

Lowest
Price Target
40.6 CNY
15% Downside
Average
Price Target
51.1 CNY
7% Upside
Highest
Price Target
63 CNY
31% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Betta Pharmaceuticals Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Betta Pharmaceuticals Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Betta Pharmaceuticals Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

20.3B CNY

Dividend Yield

0.35%

Description

Betta Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of anticancer targeted drugs. The company is headquartered in Hangzhou, Zhejiang and currently employs 1,677 full-time employees. The company went IPO on 2016-11-07. The firm's primary product is its self-developed icotinib hydrochloride (Conmana), a small molecule targeted anticancer drug used for the treatment of lung cancer. The firm is also engaged in promotional services, real estate leasing and other businesses.

Contact

ZHEJIANG
Hangzhou
No.355 Xingzhong Road, Yuhang Economic and Technological Development Zone
+8657189265665
www.bettapharma.com

IPO

2016-11-07

Employees

1 677

Officers

Founder, Chairman of the Board of Directors, CEO & GM
Dr. Lieming Ding
VP, CFO & Director
Mr. Jianxun Fan
Senior VP, COO & Director
Mr. Jiang Wan
Board Secretary & Head of Chairman Office
Mr. Lingxi Wu
President
Dr. Yinxiang Wang
Senior Director & Head of Immunology
Dr. Wenxin Xu
Show More
Vice President
Hena Shi
Vice Director of Novel Drug R & D Center
Ms. Yunyan Hu
Show Less

See Also

Discover More
What is the Intrinsic Value of one Betta Pharmaceuticals Co Ltd stock?

The intrinsic value of one Betta Pharmaceuticals Co Ltd stock under the Base Case scenario is 59.1 CNY.

Is Betta Pharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 47.95 CNY, Betta Pharmaceuticals Co Ltd is Undervalued by 19%.

Back to Top